NFKB1 and prostate carcinoma: In this study, the overexpression of SLAMF8 in prostate cancer cells caused an increase in TLR4 expression, triggered the NF-κB signaling pathway, and led to higher IL-6 secretion, potentially contributing to an immunosuppressive tumor microenvironment.